Largest licensed manufacturer for medical grade cellular therapy products in South East Asia
Asia first clinical publication using stem cell to treat genetic blindness Retinitis Pigmentosa
More than 20,000 clinical study subjects, includes but not limited to acute myocardial infarction, stroke, autism, diabetes, autoimmune and etc